- 全部删除
您的购物车当前为空
TI17 是选择性 TRIP13 抑制剂,具有抗癌活性,抑制多发性骨髓瘤 (MM) 细胞的增殖,诱导 MM 细胞的周期停滞和凋亡。


为众多的药物研发团队赋能,
让新药发现更简单!
TI17 是选择性 TRIP13 抑制剂,具有抗癌活性,抑制多发性骨髓瘤 (MM) 细胞的增殖,诱导 MM 细胞的周期停滞和凋亡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 372 | In stock | |
| 5 mg | ¥ 826 | In stock | |
| 10 mg | ¥ 1,160 | In stock | |
| 25 mg | 待询 | In stock | |
| 50 mg | 待询 | In stock |
TI17 相关产品
| 产品描述 | TI17 is a selective TRIP13 inhibitor with anticancer activity that inhibits the proliferation of multiple myeloma (MM) cells and induces cycle arrest and apoptosis in MM cells. |
| 分子量 | 374.43 |
| 分子式 | C23H22N2O3 |
| CAS No. | 1005178-02-8 |
| Smiles | O=C(O)C1C2C=CC(C1C(=O)NC3=CC=C(C=C3)CC=4C=CN=CC4)C5CC25 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容